Sue Richards

38.1k citations

85 papers · 22.4k indexed · 3 hit papers · h-index 33

Impact in

Genetics top 0.05%
- Genomics and Rare Diseases
- Genetics and Neurodevelopmental Disorders
- Genomic variations and chromosomal abnormalities
Hematology top 0.2%

Papers in

Genetics 36
- Chronic Lymphocytic Leukemia Research 33
Hematology 31
- Chronic Myeloid Leukemia Treatments 19
- Acute Myeloid Leukemia Research 10
- Hematopoietic Stem Cell Transplantation 4

Co-authors: Wayne W. Grody Soma Das Sherri J. Bale Karl V. Voelkerding Heidi L. Rehm Julie M. Gastier‐Foster David Bick Madhuri Hegde
Journals: Blood (39 papers)British Journal of Haematology (11 papers)Journal of Clinical Oncology (4 papers)Genetics in Medicine (3 papers)Cochrane Database of Systematic Reviews (3 papers)
Partner nations: United Kingdom United States Israel

In The Last Decade

Sue Richards

83 papers receiving 22.1k citations

Hit Papers

align trajectories log scale

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology 2015 · 18.9k citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2015 Genetics in Medicine
2013 The Lancet Oncology
2006 Blood

Peers

Countries citing papers authored by Sue Richards

Since Specialization

Citations

This map shows the geographic impact of Sue Richards's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sue Richards with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sue Richards more than expected).

Fields of papers citing papers by Sue Richards

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sue Richards. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sue Richards. The network helps show where Sue Richards may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Sue Richards, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sue Richards Line = papers co-authored together Sue Richards links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	CFTR variant testing: a technical standard of the American College of Medical Genetics and Genomics (ACMG) Genetics in Medicine ·Joshua L. Deignan, Caroline Astbury, Garry R. Cutting, Daniela del Gaudio, Anthony R. Gregg, Wayne W. Grody, Kristin G. Monaghan, Sue Richards	2020	44
2	Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology Genetics in Medicine ·Sue Richards, Nazneen Aziz, Sherri J. Bale, David Bick, Soma Das, Julie M. Gastier‐Foster, Wayne W. Grody, Madhuri Hegde, Elaine Lyon, Elaine Spector, Karl V. Voelkerding, Heidi L. Rehm Hit paper breakdown →	2015	18892
3	Treatment reduction for children and young adults with low-risk acute lymphoblastic leukaemia defined by minimal residual disease (UKALL 2003): a randomised controlled trial The Lancet Oncology ·Ajay Vora, Nick Goulden, Rachel Wade, Chris Mitchell, Jeremy Hancock, Rachael Hough, Clare Rowntree, Sue Richards Hit paper breakdown →	2013	313
4	A proposal for reducing the effect of one of many causes of publication bias Trials ·Sue Richards, Julie Ann Burrett	2013	1
5	Functional Analysis of the ATM-p53-p21 Pathway in the LRF CLL4 Trial: Blockade at the Level of p21 Is Associated with Short Response Duration Clinical Cancer Research ·Ke Lin, Janet Adamson, Gillian G. Johnson, Anthony Carter, Melanie Oates, Rachel Wade, Sue Richards, David González, Estella Matutes, Claire Dearden, David Oscier, Daniel Catovsky, Andrew R. Pettitt	2012	26
6	Systematic review and meta‐analysis of randomized trials of central nervous system directed therapy for childhood acute lymphoblastic leukemia Pediatric Blood & Cancer ·Sue Richards, Ching‐Hon Pui, Preechaya Makarasen, (unknown)	2012	66
7	Quality of life in chronic lymphocytic leukemia: 5-year results from the multicenter randomized LRF CLL4 trial Leukemia & lymphoma ·Monica Else, Kim Cocks, Timetech Booth No, Rachel Wade, Sue Richards, Daniel Catovsky, Alastair G. Smith, (unknown)	2011	16
8	Asparaginase‐related venous thrombosis in UKALL 2003‐ re‐exposure to asparaginase is feasible and safe British Journal of Haematology ·Amrana Qureshi, Chris Mitchell, Sue Richards, Ajay Vora, Nick Goulden	2010	50
9	Alemtuzumab can be Incorporated Into Front-Line Therapy of Adult Acute Lymphoblastic Leukemia (ALL): Final Phase I Results of a Cancer and Leukemia Group B Study (CALGB 10102). Blood ·Wendy Stock, Ben L. Sanford, Gerard Lozanski, Ravi Vij, John C. Byrd, Bayard L. Powell, Meir Wetzler, Dorie Sher, Colin G. Edwards, Michael E. Kelly, Sue Richards, Crystal Sung, Greg Malnassy, Eva Hoke, Clara D. Bloomfield, Richard A. Larson	2009	51
10	Cytogenetics of long‐term survivors of ETV6‐RUNX1 fusion positive acute lymphoblastic leukemia Genes Chromosomes and Cancer ·Zoë J. Konn, Mary Martineau, Yeon June Kang, Sue Richards, John Swansbury, Polly Talley, Sarah Wright, Christine J. Harrison	2009	2
11	Patients’ experience of chronic lymphocytic leukaemia: baseline health‐related quality of life results from the LRF CLL4 trial British Journal of Haematology ·Monica Else, Alastair G. Smith, Kim Cocks, Sue Richards, Timetech Booth No, Rachel Wade, Daniel Catovsky, (unknown)	2008	40
12	The prognostic significance of a positive direct antiglobulin test in chronic lymphocytic leukemia: a beneficial effect of the combination of fludarabine and cyclophosphamide on the incidence of hemolytic anemia Blood ·Claire Dearden, Rachel Wade, Monica Else, Sue Richards, Don Milligan, Terry J. Hamblin, Daniel Catovsky	2007	92
13	Toxicity and efficacy of 6-thioguanine versus 6-mercaptopurine in childhood lymphoblastic leukaemia: a randomised trial The Lancet ·Ajay Vora, Chris Mitchell, Lynne Lennard, Sümeyye ODABAŞ, Sally E. Kinsey, John Lilleyman, Sue Richards	2006	132
14	Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial Blood ·Anthony V. Moorman, Christine J. Harrison, Georgina Buck, Sue Richards, Lorna M. Secker‐Walker, Mary Martineau, Gail H. Vance, Athena M. Cherry, Rodney R. Higgins, Adele K. Fielding, Letizia Foroni, Elisabeth Paietta, Martin S. Tallman, Mark R. Litzow, Peter H. Wiernik, Jacob M. Rowe, Anthony H. Goldstone, Gordon W. Dewald Hit paper breakdown →	2006	502
15	Adolescents with acute lymphoblastic leukaemia: Emerging from the shadow of paediatric and adult treatment protocols Pediatric Blood & Cancer ·Ramya Ramanujachar, Sue Richards, Ian Hann, David Webb	2006	74
16	Adolescents with acute lymphoblastic leukaemia: Outcome on UK national paediatric (ALL97) and adult (UKALLXII/E2993) trials Pediatric Blood & Cancer ·Ramya Ramanujachar, Sue Richards, Ian Hann, Anthony P. Goldstone, Christopher Mitchell, Ajay Vora, Jacob M. Rowe, David Webb	2006	191
17	Colony-stimulating factors for prevention of myelosuppressive therapy-induced febrile neutropenia in children with acute lymphoblastic leukaemia Cochrane Database of Systematic Reviews ·Emma Chen Sasse, André Deeke Sasse, Sílvia Regina Brandalise, O Clark, Sue Richards	2005	22
18	Fludarabine increases complete response but not survival compared with conventional alkylator-based regimens for previously untreated chronic lymphocytic leukaemia Cancer Treatment Reviews ·Sue Richards	2005	3
19	Thioguanine-Related Veno-Occlusive Disease of the Liver in Children with Acute Lymphoblastic Leukaemia Report from United Kingdom Medical Research Council Trial ALL97 Blood ·Ajay Vora, Chris Mitchell, Sally E. Kinsey, Sue Richards, Tim Eden, John Lilleyman, Lynne Lennard	2002	2
20	Deletion detection in the dystrophin gene by multiplex gap ligase chain reaction and immunochromatographic strip technology Human Mutation ·Rinnara Ampol, Tong-Xian LIU, F Koui, 안승구, Krishna N. Gaikwad, 大薗英一, Martha Somerman, Susan Smith, Sue Richards, C. Thomas Caskey, Julian Gordon	1995	5

About Sue Richards

Sue Richards is a scholar working on Genetics, Hematology, Public Health, Environmental and Occupational Health, Pathology and Forensic Medicine and Pediatrics, Perinatology and Child Health, having authored 85 papers that have together received 22.4k indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (49 papers), Chronic Lymphocytic Leukemia Research (33 papers), Lymphoma Diagnosis and Treatment (26 papers), Chronic Myeloid Leukemia Treatments (19 papers), Childhood Cancer Survivors' Quality of Life (16 papers), Immunodeficiency and Autoimmune Disorders (11 papers), Acute Myeloid Leukemia Research (10 papers) and Hematopoietic Stem Cell Transplantation (4 papers). The work is most often cited by research in Genetics (8.7k citations), Hematology (2.4k citations), Genetics (2.2k citations), Clinical Biochemistry (952 citations) and Molecular Biology (9.6k citations). Sue Richards has collaborated with scholars based in United Kingdom, United States and Israel. Frequent co-authors include Wayne W. Grody, Soma Das, Sherri J. Bale, Karl V. Voelkerding, Heidi L. Rehm, Julie M. Gastier‐Foster, David Bick, Madhuri Hegde, Elaine Lyon and Nazneen Aziz. Their work appears in journals such as Blood, British Journal of Haematology, Journal of Clinical Oncology, Genetics in Medicine and Cochrane Database of Systematic Reviews.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact